BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen Y, Shan X, Luo C, He Z. Emerging nanoparticulate drug delivery systems of metformin. J Pharm Investig 2020;50:219-30. [DOI: 10.1007/s40005-020-00480-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Samavati SS, Kashanian S, Derakhshankhah H, Rabiei M. Nanoparticle application in diabetes drug delivery. J Nanopart Res 2022;24. [DOI: 10.1007/s11051-022-05547-8] [Reference Citation Analysis]
2 Zeb A, Gul M, Nguyen T, Maeng H. Controlled release and targeted drug delivery with poly(lactic-co-glycolic acid) nanoparticles: reviewing two decades of research. J Pharm Investig . [DOI: 10.1007/s40005-022-00584-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Chow E, Yang A, Chung CHL, Chan JCN. A Clinical Perspective of the Multifaceted Mechanism of Metformin in Diabetes, Infections, Cognitive Dysfunction, and Cancer. Pharmaceuticals 2022;15:442. [DOI: 10.3390/ph15040442] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Lee S, Ha E, Jeong J, Kim S, Park H, Kim J, Yoo J, Moon HR, Jung Y, Kim M. Determination and correlation of solubility of efinaconazole in fifteen mono solvents and three binary mixed solvents at various temperatures. Journal of Molecular Liquids 2022;349:118148. [DOI: 10.1016/j.molliq.2021.118148] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chimaobi KF, Okwudili ND, Chekwube DJ, Ugochukwu NB, Audu MM, Achile AP, Amaechi AA. Potential Enhancement of Metformin Hydrochloride in Solidified Reverse Micellar Solution-Based PEGylated Lipid Nanoparticles Targeting Therapeutic Efficacy in Diabetes Treatment. Heliyon 2022. [DOI: 10.1016/j.heliyon.2022.e09099] [Reference Citation Analysis]
6 Aldarondo D, Wayne E. Monocytes as a convergent nanoparticle therapeutic target for cardiovascular diseases. Adv Drug Deliv Rev 2022;182:114116. [PMID: 35085623 DOI: 10.1016/j.addr.2022.114116] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Chen Q, Xu S, Liu S, Wang Y, Liu G. Emerging nanomedicines of paclitaxel for cancer treatment. J Control Release 2022;342:280-94. [PMID: 35016919 DOI: 10.1016/j.jconrel.2022.01.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
8 Rodrigues A, Silva S, Oliveira M, de Oliveira G, Novais A, de Paula G, Souza D, Belo E, Gester R, Andrade-filho T. Prediction of electronic and vibrational properties of poly (hexamethylene biguanide) hydrochloride: A combined theoretical and experimental investigation. Journal of Molecular Structure 2021;1246:131176. [DOI: 10.1016/j.molstruc.2021.131176] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Duwa R, Jeong J, Yook S. Development of immunotherapy and nanoparticles-based strategies for the treatment of Parkinson’s disease. J Pharm Investig 2021;51:465-81. [DOI: 10.1007/s40005-021-00521-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]